U.S. flag

An official website of the United States government

Filters

See more specimen types...
See more states

Other countries

Results: 1 to 20 of 123

Tests names and labsConditionsGenes, analytes, and microbesMethods

Hereditary Cancer Panel Comprehensive

Molecular Genetics Laboratory London Health Sciences Centre
Canada
3930
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

BRCAssure: BRCA1 and BRCA2 Comprehensive Panel

Integrated Genetics Westborough LabCorp
United States
52
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

BRCAssure: BRCA1 and BRCA2 Deletion/Duplication Analysis

Integrated Genetics Westborough LabCorp
United States
42
  • D Deletion/duplication analysis

BRCAssure: BRCA2 Targeted Analysis

Integrated Genetics Westborough LabCorp
United States
21
  • E Sequence analysis of select exons

BRCAssure: Ashkenazi Jewish Panel

Integrated Genetics Westborough LabCorp
United States
42
  • E Sequence analysis of select exons

Invitae eMERGE Panel

Labcorp Genetics (formerly Invitae) LabCorp
United States
5916
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Common Hereditary Cancer Screening Panel

PreventionGenetics, part of Exact Sciences
United States
9455
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

BRCA1, BRCA2

Centogene AG - the Rare Disease Company
Germany
112
  • C Sequence analysis of the entire coding region

BRCA1, BRCA2 Plus

Centogene AG - the Rare Disease Company
Germany
112
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

BRCA1, BRCA2 Combi

Centogene AG - the Rare Disease Company
Germany
112
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CentoBreast

Centogene AG - the Rare Disease Company
Germany
5828
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CentoColon

Centogene AG - the Rare Disease Company
Germany
6733
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CentoCancer

Centogene AG - the Rare Disease Company
Germany
11368
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CentoCancer Comprehensive

Centogene AG - the Rare Disease Company
Germany
155107
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

BRCA1, BRCA2 Somatic

Centogene AG - the Rare Disease Company
Germany
112
  • C Sequence analysis of the entire coding region

Solid Tumor Panel

Centogene AG - the Rare Disease Company
Germany
218135
  • C Sequence analysis of the entire coding region

BRCA2 - MLPA

Centogene AG - the Rare Disease Company
Germany
81
  • D Deletion/duplication analysis

BRCA1 & BRCA2 - MLPA

Centogene AG - the Rare Disease Company
Germany
112
  • D Deletion/duplication analysis

BRCA2 - NGS including CNV analysis

Centogene AG - the Rare Disease Company
Germany
81
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Invitae Multi-Cancer + RNA Panel

Labcorp Genetics (formerly Invitae) LabCorp
United States
14263
  • D Deletion/duplication analysis

Results: 1 to 20 of 123

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.